iMedix Medical Content Engine 3.13.37
Home/Drugs/Cipro (Ciprofloxacin)

Cipro (Ciprofloxacin): Uses, Dosage & Safety Information

Cipro (Ciprofloxacin)

Cipro (Ciprofloxacin)

Cipro (Ciprofloxacin)

Ciprofloxacin
Cipro, known generically as ciprofloxacin, is a broad-spectrum fluoroquinolone antibiotic. It is prescribed to treat serious or complicated bacterial infections, including urinary tract infections, pneumonia, and certain skin infections.
  • ActiveIngredient: Ciprofloxacin
  • DosageForm: Film-coated tablet; powder for oral suspension
  • Dosage: 250 mg, 500 mg, 750 mg (tablets); 250 mg/5 mL, 500 mg/5 mL (oral suspension)
  • Indications: Skin and skin structure, bone and joint, complicated intra-abdominal infections, infectious diarrhoea, typhoid fever, uncomplicated gonorrhoea, inhalational anthrax post-exposure and plague
  • Manufacturer: Bayer HealthCare (brand Cipro); generics widely marketed
  • Storage: Store as directed on the dispensed container; keep out of reach of children
  • Drug Status: Prescription Only
Drug Status: Prescription Only
Description
Boxed warning
Fluoroquinolones cause disabling and potentially irreversible reactions that can occur together: tendinitis and tendon rupture, peripheral neuropathy, and central nervous system effects.
The instruction is to discontinue ciprofloxacin immediately and avoid fluoroquinolones altogether in anyone who experiences them. The same warning adds that these drugs may worsen muscle weakness in myasthenia gravis.1

Ciprofloxacin is a prescription fluoroquinolone antibacterial supplied as 250 mg, 500 mg and 750 mg tablets and as an oral suspension. It treats skin, bone, abdominal and urinary infections, typhoid fever, and post-exposure anthrax and plague. Cipro remains an approved Bayer brand alongside generics.2 It is listed under antibiotics on iMedix.

Its indication list is unusually wide, and includes two that most antibiotics never carry: post-exposure inhalational anthrax and plague, in adults and children. Those sit alongside ordinary infections of skin, bone, abdomen and urinary tract.1

Breadth is not the same as first choice. Because the boxed warning describes reactions that may not reverse, the label restricts several indications to patients who have no alternative treatment options.

General Instructions

Separate it from antacids, iron, zinc, calcium and dairy by several hours. These bind ciprofloxacin in the gut and can reduce absorption enough to make treatment fail.1

Drink enough fluid. Adequate hydration reduces the risk of crystals forming in the urine.

Stop and call at the first tendon pain — typically Achilles, but any tendon — and rest that limb. The same applies to new numbness, tingling, burning, confusion or agitation.1

Avoid strong sun. Ciprofloxacin can cause exaggerated sunburn reactions.

Side Effects
Reported Side Effects
SystemEffectWhat the label says
TendonsTendinitis and tendon ruptureBoxed warning; risk higher over 60, on corticosteroids, and after transplant
NervesPeripheral neuropathyBoxed warning; may be irreversible; discontinue at first symptom
Central nervous systemConfusion, agitation, seizures, psychosisBoxed warning; reported even after a single dose
NeuromuscularExacerbation of myasthenia gravisAvoided in patients with known myasthenia gravis
GastrointestinalNausea, diarrhoeaAmong the commonest reactions
SkinPhotosensitivity, severe cutaneous reactionsReported; avoid excessive sunlight
Blood vesselsAortic aneurysm and dissectionReported; risk considered in patients with existing aneurysm or risk factors

Source: 1

Emergency – stop and seek care
  • Pain, swelling or snapping in a tendon, most often behind the ankle
  • New numbness, tingling, burning or weakness in the hands or feet
  • Confusion, hallucinations, severe agitation or a seizure
  • Sudden severe pain in the chest, abdomen or back
Uses

Ciprofloxacin is indicated in adults, and in children where specified, for infections caused by designated susceptible bacteria.1

  • Skin and skin structure infections
  • Bone and joint infections
  • Complicated intra-abdominal infections
  • Infectious diarrhoea
  • Typhoid fever — enteric fever
  • Uncomplicated cervical and urethral gonorrhoea
  • Inhalational anthrax, post-exposure, in adults and children
  • Plague, in adults and children

Where the label pulls back. For acute sinusitis, acute exacerbation of chronic bronchitis and uncomplicated urinary tract infection, ciprofloxacin is reserved for patients who have no alternative treatment options, because the risk of disabling reactions outweighs the benefit in conditions that often resolve on their own.1

The anthrax and plague indications exist for a different reason: few oral antibacterials work against those organisms, and the calculus of risk changes completely when the alternative is an untreated lethal infection.

Safety Advice

Interactions Alcohol:

Consult your doctor
The label sets no alcohol restriction. Alcohol does add to the central nervous system effects the boxed warning describes — confusion and agitation — which is a reason for care rather than a formal interaction.

Interactions Other Medications:

Unsafe
Tizanidine is contraindicated outright. Antacids, iron, zinc, calcium and dairy bind ciprofloxacin in the gut and can make treatment fail unless doses are separated by hours. Corticosteroids raise tendon rupture risk, and theophylline levels rise through CYP1A2 inhibition with a risk of seizures.

Special Groups Pregnancy:

Consult your doctor
The prescribing information does not set a blanket recommendation. Fluoroquinolones are generally avoided in pregnancy where alternatives exist, and the anthrax and plague indications are the situations where that calculation changes.

Special Groups Breastfeeding:

Consult your doctor
The label does not establish a breastfeeding recommendation. The decision belongs to the clinician treating the infection.

Special Groups Elderly:

Use with caution
Age over 60 is a named risk factor for tendinitis and tendon rupture, and the risk rises further with corticosteroids. Renal function also declines with age, and ciprofloxacin is cleared by the kidney.

Special Groups Children:

Use with caution
Paediatric use is limited to specific indications — anthrax post-exposure, plague and complicated urinary tract infection — because of the musculoskeletal reactions seen with this class. It is not a general-purpose paediatric antibacterial.

Effects on Activities Driving:

Use with caution
The boxed warning includes central nervous system effects: confusion, agitation, and in rare cases seizures, reported even after a single dose. Any of these means stopping the drug and not driving until assessed.

Effects on Activities Operating Machinery:

Use with caution
The same central nervous system effects apply, with tendon injury adding a second concern for tasks requiring physical exertion.
Concerns

Cipro remains an approved Bayer brand, with one tablet application listed as discontinued and others active, and generic ciprofloxacin widely marketed.2

The concern with this drug is not availability but positioning. It is convenient, oral, broad and familiar, which makes it easy to reach for in exactly the conditions where its label says to hold back. The boxed warning describes harm that can be permanent, and the reserved indications exist to keep that risk out of infections that would settle on their own.

Warnings

The boxed warning is about reactions that may not reverse

Tendinitis and tendon rupture, peripheral neuropathy and central nervous system effects have occurred together in the same patients, and the label describes them as disabling and potentially irreversible. The instruction is not to reduce the dose but to discontinue ciprofloxacin immediately and avoid fluoroquinolones thereafter.

Tendon injury

Risk is increased in patients over 60, in those taking corticosteroids, and in kidney, heart or lung transplant recipients. Rupture has occurred during treatment and months after it ended, most often in the Achilles tendon.

Myasthenia gravis

Fluoroquinolones may exacerbate muscle weakness. The label directs avoiding ciprofloxacin in patients with a known history of the condition.

Aortic aneurysm and dissection

Reported with fluoroquinolone use. The drug is used in patients with a known aneurysm or risk factors only when no alternative is available.

Reserved indications

For acute sinusitis, acute exacerbation of chronic bronchitis and uncomplicated urinary tract infection, ciprofloxacin is reserved for patients with no alternative treatment options. These conditions frequently resolve without antibacterials, and the label weighs that against a warning about permanent harm.

Source: 1

Dosage
Approved Dosage
Indication / PopulationDose and FrequencyDuration / TimingClinical Notes
Adults: skin and skin structure infection500 to 750 mg every 12 hours7 to 14 daysDose set by severity
Adults: bone and joint infection500 to 750 mg every 12 hours4 to 8 weeksThe longest licensed course
Adults: complicated intra-abdominal infection500 mg every 12 hours7 to 14 daysUsed with metronidazole in the labelled regimen
Adults: infectious diarrhoea500 mg every 12 hours5 to 7 days—
Adults and children: inhalational anthrax post-exposurePer the anthrax dosing table60 daysDuration set by the exposure, not by symptoms

Source: 1

Stop at the first sign of a boxed-warning reaction
Tendon pain, new numbness or tingling, or confusion are reasons to stop the drug rather than to finish the course. The label directs immediate discontinuation, because these reactions may not reverse.1
▶Clinical detailstechnical detail

Ciprofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes that manage DNA supercoiling during replication. Mammalian topoisomerase II is structurally related but far less sensitive, which gives the class its selectivity — and, on current understanding, some of its off-target effects.

The tendon and neuropathy toxicity is thought to involve chelation of magnesium in collagen-rich tissue and oxidative damage to mitochondria, which is consistent with two clinical observations: risk is higher in older patients and those on corticosteroids, and onset can follow days or weeks after the course has finished.1

Interactions
Significant Interactions
Interacting substanceEffect and riskSeverityDocumentation
TizanidineMarkedly raised tizanidine concentrations with hypotension and sedation; contraindicated outrightContraindicatedExcellent
Any quinolone after hypersensitivityCross-reactivity; contraindicatedContraindicatedExcellent
Antacids, iron, zinc, calcium, sucralfate, dairyChelation in the gut substantially reduces absorption; doses are separated by several hoursMajorExcellent
CorticosteroidsRaise the risk of tendinitis and tendon rupture, particularly over 60MajorExcellent
Theophylline and other CYP1A2 substratesCiprofloxacin inhibits CYP1A2; concentrations rise, with seizure risk for theophyllineMajorExcellent
WarfarinAnticoagulant effect may increase; prothrombin time monitoredModerateGood

Source: 1

FAQs
Because fluoroquinolones can cause disabling and potentially irreversible reactions that occur together: tendinitis and tendon rupture, peripheral neuropathy, and central nervous system effects. The label directs stopping the drug immediately if any appear, and avoiding the whole class afterwards.
They have occurred during treatment and months after it ended. Achilles tendon rupture is the classic presentation, and risk is higher over 60, on corticosteroids, and after kidney, heart or lung transplantation.
Not at the same time. Calcium, magnesium, aluminium, iron and zinc bind ciprofloxacin in the gut and can reduce absorption enough for treatment to fail. Doses need separating by several hours from milk, yoghurt, antacids, sucralfate and mineral supplements.
Nausea and diarrhoea are the commonest. The ones that matter most are in the boxed warning: tendon pain or rupture, numbness or tingling in the hands and feet, and confusion or agitation. Peripheral neuropathy and joint pain are also among the six most reported terms in the FDA adverse event database.
For uncomplicated urinary tract infection the label reserves it for patients who have no alternative treatment options. The reasoning is explicit: that infection often resolves without antibacterials, and the risk of permanent harm outweighs the benefit.
Because few oral antibacterials work against Bacillus anthracis, and post-exposure prophylaxis runs 60 days. When the alternative is an untreated lethal infection, the risk calculation that restricts this drug elsewhere changes completely.
Evidence and Reported Data

Evidence scope

What we know
  • The serious reactions are named specifically and can occur together in the same patient.
  • Risk factors for tendon injury are identified: age over 60, corticosteroid use, and transplantation.
  • Three indications are formally reserved for patients with no alternative treatment options.
What remains uncertain
  • How often the disabling reactions occur is not quantified in the labelling.
  • Which patients will not recover is not predictable before treatment.
  • The mechanism behind the tendon and nerve toxicity is not established, only hypothesised.

Source: 1

What has been reported to the FDA

As of the FAERS data cut of 30 July 2026, the FDA Adverse Event Reporting System held 21,849 reports naming Cipro, of which 14,461 were classed as serious — 66% of the total.3

Most Reported Terms
Coded termReports
Drug hypersensitivity2,521
Pain1,703
Nausea1,536
Diarrhoea1,494
Peripheral neuropathy1,486
Arthralgia1,480
How to read this table

FAERS records what was reported, not what the medicine caused, and has no denominator – no count can become a rate.

Figures above are the counts held at the 30 July 2026 data cut, retrieved on 3 September 2026; they do not update between cuts.

Population note: this list is unusual. For most antibacterials the leading terms are non-specific — nausea, ineffectiveness, off-label use. Here peripheral neuropathy and arthralgia sit in the top six, and both correspond directly to what the boxed warning describes. That correspondence does not prove causation in any individual report, but it is a closer match between what is warned about and what is reported than these tables usually show.

Who was this medicine studied in?

The licensed indications cover adults from 18 years, with specific paediatric indications for anthrax post-exposure, plague and complicated urinary tract infection.1 The anthrax and plague indications rest partly on animal efficacy data, since human trials in those infections are not feasible.2

Who this is and is not appropriate for

It is not appropriate for anyone hypersensitive to any quinolone, nor for anyone taking tizanidine. It is avoided in myasthenia gravis, and used with particular caution over 60, on corticosteroids, or with an existing aortic aneurysm.1

It suits serious infection where the organism and the site justify a fluoroquinolone — bone and joint infection, complicated intra-abdominal infection, typhoid, anthrax exposure. It does not suit a sinus infection that would clear on its own.

Where to go next

References

References — verified Sep 3, 2026

  1. Ciprofloxacin tablets — prescribing information. DailyMed SPL set ID 0c355077-7361-41d0-9e82-eb31beaf5daa, version 1, effective March 6, 2025. dailymed.nlm.nih.gov. Accessed September 3, 2026.
  2. US Food and Drug Administration. Drugs@FDA: NDA 019537 Cipro tablets and NDA 020780 Cipro for oral suspension (Bayer HealthCare). Accessed September 3, 2026.
  3. US Food and Drug Administration. FDA Adverse Event Reporting System, queried through openFDA for medicinalproduct CIPRO. Data cut 2026-07-30 · Accessed 2026-09-03.

Three sources are listed because three are cited, covering FDA-approved labelling, FDA regulatory records and FDA post-marketing data.

Disclaimer

This page is medical information, not medical advice. Ciprofloxacin carries a boxed warning about disabling and potentially irreversible reactions, and several of its indications are reserved for patients with no alternative. Nothing here replaces assessment by the clinician treating you.

Advertising Disclosure: This page contains advertising. iMedix does not sell, dispense, or distribute medications, and is not responsible for transactions conducted on third-party websites. Advertising does not influence our medical content, which is independently written and reviewed by licensed healthcare professionals. See our Advertising Policy for details.